  0086-18989305995        sales@mosinterchem.com
You are here: Home / Products-list / Pharmaceutical Chemicals API / Antibiotic Drugs API / Abacavir Sulphate CAS 188062-50-2

PRODUCT CATEGORY

PRODUCTS DETAILS

loading

Abacavir Sulphate CAS 188062-50-2

Place of Origin: Zhejiang,China (Mainland)
Molecular Formul: C14H18N6O H2SO4
Molecular Weight: 384.41
Mp: 222-225°C
CAS NO.: 188062-50-2
  • 188062-50-2

  • MOSINTER

  • 188062-50-2

Availability:
Product Description

Payment   &   Shipping Terms

Supply   Capacity

Payment   Terms:

T/T, WU

Production     Capacity:

1000kg/year

Min.   Order:

1 Gram

Packing:

According to the customer's requirements 

Means   of   Transport:

Ocean, Air, Land

Delivery   Date:

7 days

 

Abacavir Sulphate

CAS 188062-50-2

Abacavir Sulfate, an indication for the treatment of human immunodeficiency virus (HIV) infection in adults, is combined with antiretroviral therapy.

We can customize according to customer's requirement.

If you have any question pls mail us or call us.


Previous: 
Next: 
PRODUCT INQUIRY
If you would like to have a question then get in touch today, we are ready to assist 24/7.
We welcome your cooperation and we will develop with you.
Factory-direct Connectivity Solutions.
High quality, Competitive Price.
Custom-tailored solutions.
Problem-solving approach.

ABOUT US

MOSINTER GROUP was established in 2004. The main office is located in Ningbo, China. The production are located in Zhejiang Province, Jiangsu Province and Shandong Province in China. Specializing in the production and marketing of chemical products, MOSINTER GROUP has excellent production equipment and a high-performing sales team as well as advanced manufacturing technique, comprehensive quality management system and modernized testing methods.

QUICK LINK

CONTACT INFO

  0086-18989305995
 0086-574-88212215
  sales@mosinterchem.com
  YinXianDaDao 1357, Guangbo Center Office 2003, Ningbo, Zhejiang, China
 forwardcy
 0086-18989305995
 0086-18989305995
Copyright  2020 Mosinter Group Limited All rights reserved.